


The Fund aims to achieve a long-term return, in excess of the long-term return that is typically achieved from US Smaller companies equity markets ('“the US'”).
| Name | % Net Assets |
|---|---|
| Tellabs | 2.4% |
| Phillips-Van Heusen | 2.2% |
| Inverness Medical Innovations | 2.2% |
| Solera | 2.2% |
| WMS Industries | 2.0% |
| Hanover Insurance Group | 1.9% |
| Omniture | 1.9% |
| Capitalsource | 1.8% |
| Freightcar America | 1.8% |
| Western Alliance Bancorp | 1.8% |
| Key | % Net Assets |
|---|---|
| 2.4% | |
| 2.2% | |
| 2.2% | |
| 2.2% | |
| 91% |
| Date | 14-Aug-2009 |
|---|---|
| NAV | 272.96p |
| Currency | GBP |
| Change | 4.27p |
| % | 1.59% |
| YTD change | 272.96p |
| YTD % | n/a |
| Fund Inception | n/a |
|---|---|
| Fund Manager | Chuck Purcell / Bill Gerlach |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £100000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | -0.03 |
You are here: research